| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.02 | 0.9 |